Related Experiment Video
Updated: Sep 23, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
[Severe respiratory symptoms following the use of waterproofing sprays]
F Bonte1, A Rudolphus, K Y Tan
1Sint Franciscus Gasthuis, afd. Longziekten, Kleiweg 500, 3045 PM Rotterdam.
Abstract:
Five patients became short of breath following the use of a waterproofing spray in an unventilated room: one 40-year-old woman and 4 men aged 40, 18, 21 and 39 years, respectively. After treatment the complaints diminished within the course of a few weeks. Waterproofing sprays are commonly used to make clothing and shoes water-repellent. Several hours after inhalation of such sprays symptoms of dyspnoea can occur. Without therapy this can lead to pulmonary fibrosis. Corticosteroid therapy seems to shorten the duration of complaints in the acute phase and preclude fibrosis. It is therefore advisable to present patients with respiratory complaints following inhalation of waterproofing sprays at an emergency department. A chest X-ray and blood gas analysis should be performed. In case of abnormalities, patients should be hospitalised.
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma III: Clinical Manifestations
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pulmonary Cycle: Exhalation
Breathing
Acute Respiratory Failure-III

